ArticleOncotarget2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.
Narendra Bharathy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleOncotarget2017
Narendra Bharathy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.